Physician profile
William E Burak
NPI 1518159417
$2,350.19
in general payments reported to CMS, 2019-2025
12 companies · $29.57 in 2025
The $29.57 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $123 · 2021: $16.38 · 2022: $215 · 2023: $425 · 2024: $398 · 2025: $29.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $1,050.00 | 2019 | |
| Myriad Genetic Laboratories, INC. | $369.26 | 2021-2024 | Bracanalysis Cdx, Myrisk |
| Hologic Sales and Service, LLC | $338.43 | 2023-2025 | Localizer, Biozorb, Trunode |
| Hologic INC | $294.91 | 2020-2022 | |
| Leica Microsystems INC. | $121.25 | 2022-2024 | Neoprobe |
| Carl Zeiss Meditec, INC. | $78.37 | 2019 | |
| Integra Lifesciences Corporation | $21.99 | 2024 | Integra, Surgimend, Omnigraft |
| Merck Sharp & Dohme LLC | $21.03 | 2023 | Lynparza, Keytruda |
| Ethicon US, LLC | $20.68 | 2023 | Harmonic |
| Medtronic, INC. | $19.73 | 2024 | Plasmablade(Tm) |
| Focal Therapeutics, INC. | $14.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Burak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.